Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+1.3%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2023 | 47.75% |
| Q4 2022 | 59.33% |
| Q3 2022 | 29.41% |
| Q2 2022 | -87.43% |
| Q1 2022 | 65.12% |
| Q4 2021 | -23.81% |
| Q3 2021 | 34.38% |
| Q2 2021 | -28.00% |
| Q1 2021 | 10.71% |
| Q4 2020 | 24.32% |
| Q3 2020 | -32.14% |
| Q2 2020 | 22.22% |
| Q1 2020 | -2.86% |
| Q4 2019 | -52.17% |
| Q3 2019 | 11.54% |
| Q2 2019 | -52.94% |
| Q1 2019 | 63.83% |
| Q4 2018 | 28.79% |
| Q3 2018 | -607.69% |
| Q2 2018 | 181.25% |
| Q1 2018 | 44.83% |
| Q4 2017 | -31.82% |
| Q3 2017 | 15.38% |
| Q2 2017 | 10.34% |
| Q1 2017 | -31.82% |
| Q4 2016 | 0.00% |
| Q3 2016 | 37.14% |
| Q2 2016 | -150.00% |
| Q1 2016 | -120.47% |
| Q4 2015 | 77.32% |
| Q3 2015 | -682.12% |
| Q2 2015 | 90.82% |
| Q1 2015 | -753.39% |
| Q4 2014 | 74.61% |
| Q3 2014 | -226.68% |
| Q2 2014 | 87.48% |
| Q1 2014 | 30.16% |
| Q4 2013 | -384.62% |
| Q3 2013 | 23.53% |
| Q2 2013 | -260.93% |